0001575872-22-000722 Sample Contracts

EXHIBIT A SECURITIES PURCHASE AGREEMENT and escrow agreement MDNA Life Sciences, Inc. SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • Delaware

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made as of the ___ day of _________________, 2018 by and among MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature page hereto (each a “Purchaser” and together the “Purchasers”).

AutoNDA by SimpleDocs
FIRST AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENT
License Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances

THIS First Amendment to the December 22, 2017 License Agreement ("First Amendment"), effective as of the date last written below (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and Laboratory Corporation of America Holdings ("LabCorp"). MDNA and LabCorp may be referred to herein each as a "Party" or collectively as "Parties."

SECOND AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENT
License Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances

THIS Second Amendment to the December 22, 2017 License Agreement ("Second Amendment"), effective as of the date of execution by both parties (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and Laboratory Corporation of America Holdings ("LabCorp"). LabCorp and MDNA may be referred to herein each as a "Party" or collectively as "Parties."

LICENSE AGREEMENT
License Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • Delaware

This License Agreement ("Agreement") is entered into by and between MDNA Life Sciences Inc., a Delaware corporation ("MDNA"), and Laboratory Corporation of America Holdings, a Delaware corporation ("LabCorp"), as of the 22nd day of December, 2017 (the "Effective Date").

DATED 21 March 2019
Lease • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • England and Wales

MDNA LIFE SCIENCES (UK) LIMITED (company number 05386828) whose registered office is at 83 Kingfisher House, Kingsway, Team Valley, Gateshead, Tyne & Wear NE11 OJQ

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!